The Study
Gut microbiota responses to isocaloric macronutrient modulation in tissue-specific insulin resistance: a secondary analysis of the PERSonalized glucose Optimization through Nutritional intervention (PERSON) randomized trial
This study gave different diets to people and saw what happened to their bodies and gut bugs. It’s like seeing that kids who ate more carrots got better at running — but we don’t know if the carrots made them faster, or if they were just the kids who already ran more. So we know the diet helped, but the gut bugs are just a clue, not proof.
Analysis score
Maximum 72 for a cohort study.
Where the score came from
This study tested two diets on people with different types of insulin resistance — one where the liver doesn't respond well to insulin, and one where the muscles don't. It looked at whether their gut bacteria changed.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 564 / 100
Quality score
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Yes — if your insulin problem is mainly in your liver, eating more healthy fats like olive oil may help by changing your gut bacteria to reduce inflammation and improve metabolism.
- 2If your problem is in your muscles, this diet won't change your gut bugs — so other strategies may be needed.
- 3In liver-predominant insulin resistance: HMUFA diet (like olive oil) changed gut bacteria to more good, short-fat-acid makers, and lowered inflammation.
- 4In muscle-predominant: no gut bacteria changes happened.
- 5A specific bacteria (Barnesiella) was linked to better muscle insulin sensitivity in the HMUFA group.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
The American Journal of Clinical Nutrition
Year
2026
Authors
Kelly M Jardon, Alexander Umanets, Koen Venema, Inez Trouwborst, Anouk Gijbels, Gabby B Hul, Els Siebelink, Lydia A Afman, Gijs H Goossens, Ellen E Blaak
Related Content
Claims (5)
In adults with liver insulin resistance, eating a 12-week diet high in monounsaturated fats changes gut bacteria to increase short-chain fatty acid producers, and this change is linked to lower inflammation and better insulin sensitivity.
In adults with muscle insulin resistance, eating a 12-week diet high in monounsaturated fats without changing total calories does not change the gut microbiome or improve metabolism, suggesting the gut microbiome does not drive these metabolic outcomes in this group.
In adults with insulin resistance in the liver or muscles, a 12-week diet low in fat but high in protein and fiber causes only small changes in gut bacteria compared to a diet high in monounsaturated fats.
In adults with muscle-predominant insulin resistance, higher initial levels of the gut bacteria Barnesiella are associated with greater improvement in muscle insulin sensitivity after consuming a high-monounsaturated fat diet.
People with insulin resistance primarily affecting the liver show a stronger change in their gut bacteria when they change their diet compared to people with insulin resistance primarily affecting their muscles.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.